Therapeutic actions reported: Antibacterial Antipathogenic
← Scroll →
ⓘ Table glossary
Table glossary
ReferencePubMed ID of research paper
Experiment TypeIn vivo or in vitro
Cell / Tissue / Microbe / Strain If in vitro, cells = cells from aquaculture-relevant species
Cell / Tissue / Microbe / Strain If in vitro, tissues = tissues from aquaculture-relevant species
Cell / Tissue / Microbe / Strain If in vitro, microbes = type of microorganism obtained from aquaculture-relevant species
Cell / Tissue / Microbe / Strain If in vitro, strain = strain of microorganism obtained from aquaculture-relevant species
Cell / Tissue / Microbe / Strain If in vivo, this field is left blank
Test OrganismAquaculture-relevant species tested for prophylactic effect
LifestageLifestage of test organism if reported
Administration MethodRoute or method of chemical administration
Target OrganismPathogens affecting the test organism
Administered Dose RangeAll tested chemical doses
Significant Dose RangeDoses producing significant effects
Time to DeathTime to kill target organism (minutes)
Anthelminthic EfficacyEffectiveness in reducing target organism (%)
Therapeutic ActionReported therapeutic effect
Reference Experiment Type Cell/Tissue/Microbe/Strain Test Organism Lifestage Administration Method Target Organism Administered Dose Range Significant Dose Range Time to Death of Pathogen (min) Anthelminthic Efficacy (%) Therapeutic Action
PMID:39120127 In vitro RTMCX1 (JX390650) - - - Aeromonas hydrophila 32.0
μg/mL
32.0
μg/mL
- - Antibacterial
In vitro RTFG299 (OQ257343) - - - Chryseobacterium aquaticum 4.0
μg/mL
4.0
μg/mL
- - Antibacterial
In vitro RTFCP446298 (OP604185) - - - Chryseobacterium balustinum 32.0
μg/mL
32.0
μg/mL
- - Antibacterial
In vitro RTCLI04 (KM604704) - - - Lactococcus garvieae 1.0
μg/mL
1.0
μg/mL
- - Antibacterial
In vitro GCAFBLC228 (MK245984) - - - Aeromonas veronii 1.0
μg/mL
1.0
μg/mL
- - Antibacterial
In vitro MHJL248 (MN900589) - - - Vibrio anguillarum 32.0
μg/mL
32.0
μg/mL
- - Antibacterial
In vitro MHJL258 (MN904977) - - - Shewanella xiamenensis 0.25
μg/mL
0.25
μg/mL
- - Antibacterial
In vitro MHJM250 (MN900593) - - - Aeromonas salmonicida 32.0
μg/mL
32.0
μg/mL
- - Antibacterial
PMID:17292447 In vitro Bacteria - - - Vibrio fischeri 0.198
mg/L
0.198
mg/L
- - Antibacterial
PMID:28627489 In vivo - Danio rerio Embryo Bath Francisella noatunensis ssp. orientalis 100.0
μg/mL
100.0
μg/mL
- - Antipathogenic
In vivo - Danio rerio Embryo Encapsulated into nano structured lipid carriers & then injected Francisella noatunensis ssp. orientalis 7.4
μg/mL
7.4
μg/mL
- - Antipathogenic
Glossary ×
ReferencePubMed ID of research paper
Experiment TypeIn vivo or in vitro
Cell / Tissue / Microbe / Strain If in vitro, cells = cells from aquaculture-relevant species
Cell / Tissue / Microbe / Strain If in vitro, tissues = tissues from aquaculture-relevant species
Cell / Tissue / Microbe / Strain If in vitro, microbes = type of microorganism obtained from aquaculture-relevant species
Cell / Tissue / Microbe / Strain If in vitro, strain = strain of microorganism obtained from aquaculture-relevant species
Cell / Tissue / Microbe / Strain If in vivo, this field is left blank
Test OrganismAquaculture-relevant species tested for prophylactic effect
LifestageLifestage of test organism if reported
Administration MethodRoute or method of chemical administration
Target OrganismPathogens affecting the test organism
Administered Dose RangeAll tested chemical doses
Significant Dose RangeDoses producing significant effects
Time to DeathTime to kill target organism (minutes)
Anthelminthic EfficacyEffectiveness in reducing target organism (%)
Therapeutic ActionReported therapeutic effect
DISCLAIMER

ReCAnt is a database of chemicals used in aquaculture and their ecotoxic effects, compiled from published literature. The authors are not liable for any inaccuracies or omissions of any chemicals in this resource. Importantly, our sole goal to build this resource on chemicals used in aquaculture is to enable future basic research on this topic, and it does not necessarily reflect the views or objectives of our employers or funders.